“Brand Name or Equal” Nanalysis AUTOsample-100 autosampler
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), on behalf of the Office of Pharmaceutical Quality Research (OPQR), is conducting market research to identify sources for a “Brand Name or Equal” Nanalysis AUTOsample-100 autosampler. This is a Sources Sought announcement, not a request for proposal. Capability statements are due by May 26, 2026, at 1:00 PM Central Time.
Scope of Work
The FDA's OPQR in Saint Louis, MO, requires an autosampler for an existing Nanalysis 100 MHz benchtop NMR system. The purpose is to significantly improve laboratory efficiency by automating sample handling, enabling unattended operation, and increasing throughput. The autosampler must be newly manufactured and a turn-key solution, including installation and training.
Minimum Technical Requirements (Salient Characteristics):
- Compatible with and fully integrated with the existing Government-owned Nanalysis 100-PRO benchtop NMR system (Serial Number C109122022).
- Support automated queuing and execution of multiple NMR experiments and samples without operator intervention.
- Enable automated magnetic field shimming and lock adjustments between queued experiments and samples.
- Operate using existing Nanalysis software and control environment without custom third-party integration.
Contract & Timeline
- Type: Sources Sought / Market Research
- NAICS: 334516 - Analytical Laboratory Instrument Manufacturing (Size Standard: 1,000 employees)
- Set-Aside: Primarily seeking small business sources, but all interested vendors (including other than small businesses and those offering domestic products) are encouraged to respond.
- Response Due: May 26, 2026, 1:00 PM Central Time
- Published: May 18, 2026
- Place of Performance: FDA/CDER/OPQR, 645 Newstead Ave., St Louis, MO 63110
- Delivery: Within 60 calendar days from date of award (if a solicitation results).
Response Requirements
Interested contractors must submit capability statements demonstrating regular engagement in the sale of similar products/services. Responses must include:
- Business name, bio, UEI, address, website, business size status (e.g., SB, VOSB, LB), and point of contact information.
- Past performance information for similar products/services, including client details and manufacturer information.
- Descriptive literature, brochures, and sufficient technical information to confirm compliance with requirements.
- Identification of any Best in Class (BIC) or GSA Schedule contracts.
- Place of product manufacture for Buy American Act considerations.
- Informational pricing is desired.
Additional Notes
This is for market research purposes only and is not a solicitation or a guarantee of a future contract. The Government will not pay for information provided. Responses must demonstrate capability, not merely affirm it. No proprietary or confidential information should be included.